Comparison of the response observed in the dominant and non-dominant hands when assessing neuromuscular block using the TOF-Watch® SX

Comparison of neuromuscular monitoring in the dominant and non-dominant hand using the TOF-Watch® SX: a single-centre randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN82219498

Enrollment

Registered

2009-10-14

Start date

2008-04-01

Completion date

Unknown

Last updated

2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Routine surgery/neuromuscular block Surgery Routine surgery

Interventions

After pre-oxygenation, all patients will receive a standard anaesthetic regimen consisting of intravenous infusions of propofol (0.1 - 8.0 µg/ml) and remifentanil (0.1 - 1.0 µg/kg/min) for induction a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. American Society of Anaesthesiologists (ASA) grade I - III 2. Aged 18 - 65 years, either sex 3. Undergoing planned, elective surgery

Exclusion criteria

Exclusion criteria: 1. Patients with known neuromuscular disease 2. Patients on medication known to interact with neuromuscular blocking agents 3. Pregnancy 4. Patients with known allergy to neuromuscular blocking agents 5. Patients with a known or suspected risk of difficult intubation

Design outcomes

Primary

Measure	Time frame
Time to return of TOF (train-of-four) ratio to 0.9	—

Secondary

Measure	Time frame
1. Tme to onset of block 2. Time to return of T1 to 25%	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026